Mechanical valves used for aortic valve replacement (AVR) continue to be associated with
bleeding risks because of anticoagulation therapy, while bioprosthetic valves are at risk of …

In recent times, there has been a considerable increase in the use of aortic bioprostheses
(vs. mechanical prostheses) for treating aortic valve disease, and this tendency is likely to …

Abstract Aims The Valve Academic Research Consortium (VARC), founded in 2010, was
intended to (i) identify appropriate clinical endpoints and (ii) standardize definitions of these …

Choosing the right valve for the right patient is a difficult but essential process to optimize the
outcome for patients undergoing valve replacement. The first step in this decisionmaking …

ACE has been identified in aortic sclerotic lesions. 13 Although there is evidence that some
ACE may be produced locally, the majority was extracellular and colocalized with …

Background: Scarce data exist on the incidence of and factors associated with valve
hemodynamic deterioration (VHD) after transcatheter aortic valve replacement (TAVR) …

Transcatheter aortic valve implantation (TAVI) has become the standard of care for
inoperable patients, and the preferred treatment option for high-risk patients with severe …

Aims A comprehensive description of transcatheter heart valve (THV) failure has not been
performed. We undertook a systematic review to investigate the aetiology, diagnosis …

Bioprosthetic valve use has increased significantly. Considering their limited durability, there
will remain an ongoing clinical need for repairing or replacing these prostheses in the future …

Background—Although short-and medium-term outcomes after transcatheter aortic valve
implantation are encouraging, long-term data on valve function and clinical outcomes are …